hydroxyindoleacetic acid has been researched along with Hypertension, Malignant in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lachhein, L | 1 |
Schütz, J | 1 |
1 other study available for hydroxyindoleacetic acid and Hypertension, Malignant
Article | Year |
---|---|
[Simple test for pheochromocytoma as well as neuroblastoma and small intestine carcinoids. Analysis of 3-methoxy-4-hydroxymandelic acid, 3-methoxy-4-hydroxyphenylacetic acid and 5-hydroxy-indoleacetic acid in urine by chromatoelectrophoresis].
Topics: Antihypertensive Agents; Carcinoid Tumor; Chromatography; Electrophoresis; Humans; Hydroxyindoleacet | 1967 |